Dr. Agarwal's Health Care Limited — PPTs, 21-05-2026: Investor Presentation

**Business Performance:** Dr. Agarwal’s Health Care reported robust FY26 results, with total income rising 20.9% to ₹2,125 Cr. EBITDA grew 22.2% to ₹614 Cr, and profit after tax surged 52.4% to ₹168 Cr. The company served over 3 million patients and performed 323K surgeries, highlighting strong operational expansion primarily in India.

**Growth Drivers & Strategy:** Key growth drivers include an aggressive network expansion, with 57 new facilities added in FY26 across 26 new cities, expanding to 288 eye care centers. The company leverages an asset-light hub-and-spoke model and its proprietary AI-ready Hospital Management System "Neo" for scalable and efficient operations.

**Recent Developments:** The company maintains a strong focus on clinical excellence, with doctors receiving industry awards, contributing to over 360 peer-reviewed publications, and advancing 13 clinical research studies. Capacity expansion continues with the opening of several new surgical facilities.

**Key Financial Metrics (FY26):**

- Total Income: ₹2,125 Cr (+20.9% YoY)

- EBITDA: ₹614 Cr (+22.2% YoY)

- PAT: ₹168 Cr (+52.4% YoY)

- Patients Served: 3.01 million (+23.7% YoY)

**Management Outlook:** Management plans to add 60 more facilities in FY27, aiming to capitalize on India’s large and rapidly expanding eye care market. The focus remains on efficient scaling through its integrated network and leveraging technological advancements.